Immunomedics (IMMU) - moderated | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Immunomedics (IMMU) - moderated

An SI Board Since September 2006

Posts	SubjectMarks	Bans	Symbol
63364	356	15	IMMU

Emcee: idahoranch1	Type: Moderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
63124	I heard that new guy at FDA that spooked everyone (Prasad) about SRPT was interv	stockdoc77	9	5/28/2025
63123	Trodelvy® Demonstrates Highly Statistically Significant & Clinically Me	Olecranon	10	5/23/2025
63122	Sarepta Provides Update on UK Dosing in ENVISION Study of ELEVIDYS for the treat	luckydog88	3	5/21/2025
63121	Thanks again for all that, allatwwk. I’m surprised that UNH medicare fraud was	Olecranon	-	5/19/2025
63120	I enjoyed the conference a lot. Panel after panel, really good questions from a	allatwwk	1	5/17/2025
63119	Thanks, allatwwk. Were you happy with the quality of the information presented?	Olecranon	-	5/17/2025
63118	Sarepta Therapeutics Shares New Protein Expression and Safety Results from ENDEA	luckydog88	2	5/16/2025
63117	Companies ranked high on innovation and invention at the STAT conference. The pr	allatwwk	2	5/15/2025
63116	Approval by Japan is a huge vote of confidence in elevydis. The Japanese are no	stockdoc77	10	5/14/2025
63115	ctmx acquired price abbv imgn approved product 1 indication	forgetme	-	5/13/2025
63114	for those following srpt: Sarepta Therapeutics Announces Approval in Japan of EL	luckydog88	3	5/13/2025
63113	ctmx abbv met adc data medium 3rd line pts were not as sick Efficacy: ORR: 18%	forgetme	1	5/12/2025
63112	ctmx great data and wider application than immu trop adc	forgetme	-	5/12/2025
63111	Not to mention polluting the oceans	EMU2	-	5/10/2025
63110	couple of more analysts on SPRT today/yesterday afternoon: Wells Fargo analyst	luckydog88	1	5/8/2025
63109	This is hilarious: "Dumping cargo at sea to avoid tariffs..." scmp.c	ghettogoulash	-	5/8/2025
63108	Tariffs: it's not playing out that way so far. Whatever happened to Canada s	ghettogoulash	-	5/8/2025
63107	Thanks for the gumball, Mickey. When SRPT is back to $113-125 in twelve months o	ghettogoulash	1	5/7/2025
63106	SRPT this morning: Morgan Stanley analyst Matthew Harrison maintains Sarepta Th	luckydog88	2	5/7/2025
63105	It's a rare occurrence when I turn on early morning CNBC (Squawk Box) and se	CelebrityEquity	-	5/7/2025
63104	Quick summary of SRPT 1st quarter report. Earnings massively missed, but revenue	Olecranon	-	5/6/2025
63103	it certainly is hard not to feel like the new leadership is going to cause some	luckydog88	5	5/6/2025
63102	“FDA Commissioner Marty Makary named Vinay Prasad as the next director of the Ce	Olecranon	1	5/6/2025
63101	Miai d1io3yog0oux5.cloudfront.net phase 3 product with multiple indication sim	forgetme	-	5/4/2025
63100	allatwwk, thanks for doing this, and generously offering to get questions answer	Olecranon	-	5/2/2025

Go to reply# or date (mm/dd/yy):